![Javier Lopez Martinez](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Javier Lopez Martinez
Corporate Officer/Principal at
University of Santiago de Compostela
Profile
He studied Economics at Santiago University.
"Stagiaire" of the Galicia-Europa Foundation in Brussels.
For the past 5 years he has served as Head of the New Innovative Business Program for the Galician Economic Promotion Institute, and during this same time period, was member of the Investment Committee for the Emprende Fund (Innovative Businesses) of Xesgalicia SGECR.
He has also worked in the Luso Español Bank, part of the Caixa Geral de Depositos Group, was responsible for the European Business Information Centre for the Galician Business Confederation.
Since January 2001 he has worked as Investment Director at UNIRISCO GALICIA, SCR.
He is a regular Lecturer in the Masters in Banking and Finance Program at Santiago University, and he collaborates in different training programs for the creation and financing of technological businesses in various universities and business organizations throughout Spain and Portugal.
Javier Lopez Martinez active positions
| Companies | Position | Start |
|---|---|---|
University of Santiago de Compostela
 University of Santiago de Compostela Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Former positions of Javier Lopez Martinez
| Companies | Position | End |
|---|---|---|
Unirisco Galicia
 Unirisco Galicia Investment ManagersFinance UNIRISCO is an active manager which invests in innovative technology projects based on research from the universities of Santiago and Vigo in all sectors except finance. They focus their investments in Spain, Northern Portugal and the Galicia region, particularly in areas where the universities of Santiago and Vigo have a socio-economic impact. Other areas are taken into consideration, provided they are of socio-economic benefit to Galicia. The firm selects investments through the University of Santiago's business promotion group, UNINOVA, seeking to invest EUR 100,000-300,000 in companies with a capable management team, an innovative business project, significant growth and profitability prospects and a stable and verifiable business plan. They typically invest up to EUR 450,000 as sole investor and co-invest in syndication with venture capital partners for larger amounts. UNIRISCO takes minority stakes and a seat on the board of directors in the companies in which they participate, partnering with the investee company to help them develop a market for their products and provide them with national and international contacts. The firm generally holds an investment for three to ten years, preferring to exit through a sale to the investee company's original shareholders. | Chief Investment Officer | 01/01/2009 |
Advancell Advanced In Vitro Cell Technologies SL
 Advancell Advanced In Vitro Cell Technologies SL BiotechnologyHealth Technology Designs and develops pharmaceutical products | Director/Board Member | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
3
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Unirisco Galicia
Unirisco Galicia Investment ManagersFinance UNIRISCO is an active manager which invests in innovative technology projects based on research from the universities of Santiago and Vigo in all sectors except finance. They focus their investments in Spain, Northern Portugal and the Galicia region, particularly in areas where the universities of Santiago and Vigo have a socio-economic impact. Other areas are taken into consideration, provided they are of socio-economic benefit to Galicia. The firm selects investments through the University of Santiago's business promotion group, UNINOVA, seeking to invest EUR 100,000-300,000 in companies with a capable management team, an innovative business project, significant growth and profitability prospects and a stable and verifiable business plan. They typically invest up to EUR 450,000 as sole investor and co-invest in syndication with venture capital partners for larger amounts. UNIRISCO takes minority stakes and a seat on the board of directors in the companies in which they participate, partnering with the investee company to help them develop a market for their products and provide them with national and international contacts. The firm generally holds an investment for three to ten years, preferring to exit through a sale to the investee company's original shareholders. | Finance |
Advancell Advanced In Vitro Cell Technologies SL
Advancell Advanced In Vitro Cell Technologies SL BiotechnologyHealth Technology Designs and develops pharmaceutical products | Health Technology |
University of Santiago de Compostela
University of Santiago de Compostela Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Javier Lopez Martinez
